Biosafety Testing Sample Clauses
The Biosafety Testing clause establishes requirements for evaluating the safety of biological materials or products to ensure they do not pose risks to human health or the environment. Typically, this clause outlines the types of tests that must be conducted, such as screening for contaminants or verifying compliance with regulatory standards, and may specify who is responsible for performing and documenting these tests. Its core function is to mitigate potential hazards associated with biological substances, thereby protecting users and meeting legal or industry safety obligations.
Biosafety Testing. Diaclone shall conduct and pay for the Biosafety Testing in accordance with Exhibit F attached hereto (provided that Xcyte shall pre-approve any costs that materially differ from the estimated costs set forth in Exhibit F attached hereto) and invoice Xcyte for reimbursement. Xcyte shall pay all undisputed amounts on such invoice within forty-five (45) days of receipt thereof.
Biosafety Testing. Diaclone agrees to conduct, at Xcyte’s expense, biosafety testing (the “Biosafety Testing”) on all Licensed Antibody to be provided to Xcyte hereunder and under any Purchase Order. The specifications of the tests included in the Biosafety Testing, and the estimated costs therefor, are set forth in Exhibit F attached hereto. Diaclone shall provide to Xcyte all data, results and materials relating to the Biosafety Testing.